Please login to the form below

Not currently logged in

inherited retinal disease

This page shows the latest inherited retinal disease news and features for those working in and with pharma, biotech and healthcare.

Biogen's ALS drug tofersen misses phase 3 endpoint

Biogen's ALS drug tofersen misses phase 3 endpoint

ALS community, and we welcome this important research advancement in this difficult to treat disease space.”. ... retinitis pigmentosa, a rare, inherited retinal disease that is associated with progressive vision loss, in May.

Latest news

More from news
Approximately 3 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...